The mass-produced COVID-19 vaccines built using the mRNA model – which were rapidly manufactured during the global pandemic – could also help the immune system recognise and attack cancer tumours, new studies have shown.

Studies in mice and an analysis of medical records of cancer patients – who received mRNA shots for COVID-19 before starting immunotherapy for cancer treatment – revealed a startling pattern: the vaccinated patients lived significantly longer than those who had not received the shots.

A team of researchers from the University of Florida and the University of Texas MD Anderson Cancer Center presented the results this week at the European Society for Medical Oncology Congress in Berlin and published in the peer-reviewed journal, Nature.

The results, they say, reveal tha

See Full Page